Historial de carrera de David L. Snitman
Antiguos cargos conocidos de David L. Snitman.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ARRAY TECHNOLOGIES, INC. | Director/Miembro de la Junta | 11/10/2010 | 24/10/2012 |
| Director de Operaciones | 01/05/1998 | 02/03/2015 | |
| Fundador | 01/01/1998 | 30/06/2015 | |
| Corporate Officer/Principal | 02/03/2015 | 30/06/2015 | |
| AMGEN INC. | Director Técnico/Científico/I+D | 01/12/1981 | - |
BaroFold, Inc.
 BaroFold, Inc. Pharmaceuticals: MajorHealth Technology BaroFold, Inc. develops and commercializes protein therapeutics. Its services include protein refolding, protein analytical and aggregate characterization, formulation stability and immunogenicity studies, and microbial expression. The company was founded by Matthew Seefeldt, Matthew Brewer, John F. Carpenter, Ted Randolph, Timothy C. Rodell, and Lyndal K. Hesterberg in 2009 and is headquartered in Aurora, CO. | Director/Miembro de la Junta | - | - |
Formación de David L. Snitman.
| Northeastern University | Undergraduate Degree |
| The University of Colorado | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 6 |
Operativa
| Director/Board Member | 2 |
| Chief Operating Officer | 1 |
| Founder | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| AMGEN INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Array BioPharma, Inc.
 Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Array BioPharma, Inc. is a biopharmaceutical company. Its focus is on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. The company's products are BRAFTOVI and MEKTOVI. Its portfolio includes Binimetinib, Selumetinib, Encorafenib, Filanesib, Ipatasertib, Varltinib, Danoprevir, ARRY-797, Larotrectinib, Tucatinib, ARRY-382, Motolimod, Prexasertib, GDC-0575, LOXO-292, LOXO-195, and AK-1830. The company was founded by Kevin Koch, Anthony D. Piscopio, K. C. Nicolaou, and David L. Snitman in 1998 and is headquartered in Boulder, CO. | Health Technology |
BaroFold, Inc.
BaroFold, Inc. Pharmaceuticals: MajorHealth Technology BaroFold, Inc. develops and commercializes protein therapeutics. Its services include protein refolding, protein analytical and aggregate characterization, formulation stability and immunogenicity studies, and microbial expression. The company was founded by Matthew Seefeldt, Matthew Brewer, John F. Carpenter, Ted Randolph, Timothy C. Rodell, and Lyndal K. Hesterberg in 2009 and is headquartered in Aurora, CO. | Health Technology |
- Bolsa de valores
- Insiders
- David L. Snitman
- Experiencia
